The Role of Melatonin as an Adjuvant Therapy in Childhood Pneumonia
Recruiting
Phase 1
Phase 2
Interventional Study
Pneumonia Childhood
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 1 Month – 12
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Mian Muhammad Hassan Ahmed · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to compare the mean length of hospital stay between children with pneumonia receiving melatonin as an adjuvant therapy and those receiving standard of care alone.
The hypothesis is that combining oral melatonin with standard treatment can reduce the length of hospital stay as compared to standard of care alone.
The control group will receive standard treatment (antibiot…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 1 month to 12 years
* Both genders
* Patient diagnosed as having pneumonia or severe pneumonia according to WHO definition
Exclusion Criteria:
* Hospitalized within 14 days prior to the study
* Known TB exposure
* Active varicella or herpes simplex infection
* Allergy to the…
Contacts
No contact information available.